By Will Boggs, MD NEW YORK (Reuters Health) – Temsirolimus does not improve progression-free survival in metastatic renal cell carcinoma (RCC) compared to standard treatment, according to results…
NEW YORK (Reuters Health) – In patients with potentially resectable colorectal liver metastases, the use of combined PET and CT imaging (PET-CT) identifies those with occult extrahepatic disease…
Recent Videos in Reuters Health • The Doctor’s Channel Newscast Page 9
NEW YORK (Reuters Health) – A European study indicates that patients with T-cell prolymphocytic leukemia may respond well to induction chemotherapy using fludarabine, mitoxantrone and cyclophosphamide, followed by…
NEW YORK (Reuters Health) – Measuring urinary levels of prostate cancer antigen 3 (PSA3) may be more accurate than PSA testing in detecting prostate cancer, but evidence is…
By David Douglas NEW YORK (Reuters Health) – Surgical resection of isolated pulmonary metastases can prolong overall survival in breast cancer patients, German researchers say. “On the basis…
By David Douglas NEW YORK (Reuters Health) – Adding lapatinib to paclitaxel provided significant benefits to women with newly diagnosed HER2-positive metastatic breast cancer in a recent study.…
NEW YORK (Reuters Health) – For women with HER2-positive breast cancer, trastuzumab is as beneficial in those with invasive lobular disease as those with invasive ductal carcinoma, according…
NEW YORK (Reuters Health) – A European study indicates that patients with T-cell prolymphocytic leukemia may respond well to induction chemotherapy using fludarabine, mitoxantrone and cyclophosphamide, followed by…
By Andrew M. Seaman New York (Reuters Health) – Women with lung cancer who ate the most soy before their diagnosis might live a little longer than those…
NEW YORK (Reuters Health) – Environmental factors appear to influence the incidence of papillary thyroid microcarcinomas (PTMCs), according to a comparison of epidemiologic data from Sicily and the…
NEW YORK (Reuters Health) – In a randomized controlled trial, the anti-CA-125 vaccine abagovomab did not prolong survival in patients with ovarian cancer in first remission — despite…
NEW YORK (Reuters Health) – Even without conventional conditioning and cytoxic chemotherapy, an allogeneic hematopoietic cell transplant (HCT) can have a substantial benefit in patients with advanced hematologic…
